Dr. Hector F. Bonilla, MD

Dr. Bonilla practices at Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University.

Dr. Bonilla's NPI, 1225115371, was assigned on November 1, 2006. Dr. Bonilla graduated from Universidad del Valle Health Sciences in 1983. Dr. Bonilla holds California license C134184.

Dr. Bonilla's primary practice is Stanford Hospital at 300 Pasteur Drive, at 300 Pasteur Drive, Stanford, CA 94305 in Santa Clara County. The practice phone is (650) 723-4000.

Dr. Bonilla's primary practice is Stanford Hospital at 300 Pasteur Drive in Stanford, California, part of Stanford University. The medical group on file is Stanford Health Care. Dmand AI also links Dr. Bonilla to 1 more hospital and 3 medical groups, each named with a free account. Dr. Bonilla's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Bonilla practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Bonilla's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Bonilla is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Bonilla's licenses on file in 5 states: California, Pennsylvania, Ohio, Louisiana and Michigan.

Dmand AI lists cold sores or genital herpes among the conditions Dr. Bonilla treats.

CMS data shows 334 Medicare services from Dr. Bonilla across 3 procedure codes in 2024, for 242 Medicare patients. Medicare paid $49,556 for them.

CMS counts 242 Medicare patients who saw Dr. Bonilla in 2024. The largest group is 65 to 74, with 102 patients. 61% of them have high cholesterol, and 45% have high blood pressure. 24% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Bonilla's median patient age at 45, with 70% women.

In 2024, Dr. Bonilla wrote 993 Medicare Part D claims for 193 patients. 96% of them were for generic drugs. CMS names the drug for 925 of them, across 13 drugs with 11 or more claims each, at $52,711 in total drug cost. In 2023, CMS named 958 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Bonilla for performance year 2024, reported as part of a group. Dr. Bonilla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Bonilla as offering telehealth.

Dmand AI links 62 papers to Dr. Bonilla, published from 2007 to 2025. 2021 was the busiest year, with 8. The most frequent topics are COVID-19, SARS-CoV-2 and Antiviral Agents. Dr. Bonilla has published most often in Clin Infect Dis. Dr. Bonilla's most frequent co-authors are Prasanna Jagannathan, MD, Aruna Kumar Subramanian, MD and Linda N. Geng.

CMS Open Payments shows 21 general payments to Dr. Bonilla from 5 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 78% of the total. Gilead Sciences, Inc. paid the most, $7,893.

Dr. Bonilla graduated from Universidad del Valle Health Sciences in 1983. Dr. Bonilla is a member of ACP.

Dr. Bonilla is in network with 11 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.